Abstract

We examine whether, why and when accessing external knowledge via loosely coupled research partnerships may increase the in-sourcing firm?s innovative performance. We argue that innovation benefits from loosely coupled partnerships (e.g. a research contract, licensing) stem not only from the sourcing relationship per se, but are closely linked to the in-sourcing firm?s experimental orientation to pursue risky projects and its availability of financial slack and managerial resources. We test our hypotheses in the global pharmaceutical industry, using a panel dataset covering the world?s largest global pharmaceutical firms between 1998 and 2007. Our results demonstrate that loosely coupled research partnerships, under certain circumstances, may provide the same type of innovation benefits typically attributed only to tightly coupled partnerships (e.g. a joint venture).

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.